Patusky Christopher's Form 4 filing
United Therapeutics Corp (UTHR) · filed Mar 20, 2025
- Accession no.
- 0001562180-25-002636
- Filed
- Mar 20, 2025
- Trade date
- Mar 19, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 8 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.55M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patusky ChristopherCIK 0001231427 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | Common Stock | MOption exerciseAcquired | +5,000 | $175.43 | +$877,150 | 5,900 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −300 | $307.73F2 | −$92,319 | 5,600 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −1,780 | $308.82F3 | −$549,699.6 | 3,820 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −328 | $309.73F4 | −$101,591.44 | 3,492 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −457 | $310.80F5 | −$142,035.6 | 3,035 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −736 | $312.22F6 | −$229,793.92 | 2,299 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −1,299 | $313.14F7 | −$406,768.86 | 1,000 | Direct | |
| Mar 19, 2025 | Common Stock | SSaleDisposed | −100 | $313.77 | −$31,377 | 900 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $307.32 to $308.125. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $308.44 to $309.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $309.48 to $310.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $310.48 to $310.89. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $311.68 to $312.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $312.735 to $313.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.